Association between opioid use and survival in advanced non small cell lung cancer patients treated with immune checkpoint inhibitors
Abstract Cancer-related pain is a frequent challenge among non-small cell lung (NSCLC) cancer patients, particularly for those with advanced disease and/or bone metastases. Opioids are the mainstay of treatment for moderate to severe cancer-related pain. However, emerging lines of evidence suggest t...
Saved in:
| Main Authors: | Luigi Liguori, Stefano Pepe, Valentina Pagliara, Rosario De Feo, Alessandro Ottaiano, Francesco Perri, Giovanna Polcaro, Valeria Conti, Cristina R. Ferrone, Francesco Sabbatino, Marco Cascella |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-15684-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma
by: Luigi Liguori, et al.
Published: (2025-09-01) -
Perioperative Chemo/Immunotherapies in Lung Cancer: A Critical Review on the Value of Perioperative Sequences
by: Thoma’ Dario Clementi, et al.
Published: (2025-07-01) -
Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications
by: Erfan Rezazadeh‐Gavgani, et al.
Published: (2025-04-01) -
Dissecting the link between PD-1/PD-L1-based immunotherapy and cancer pain: mechanisms, research implications, and artificial intelligence perspectives
by: Marco Cascella, et al.
Published: (2024-12-01) -
CK2B Induces CD8+ T‐Cell Exhaustion through HDAC8‐Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti‐PD‐1 Therapy in Non‐Small‐Cell Lung Cancer
by: Shaochuan Liu, et al.
Published: (2025-04-01)